Drug Delivery across the Blood Brain Barrier
The future of treating brain diseases.
The future of treating brain diseases.
D2B3 is a pre-clinical biotechnology company dedicated to advancing drug delivery solutions to the brain and central nervous system.
Its proprietary technology allows to transiently and specifically open the blood brain barrier for therapeutic targeting of CNS diseases with high efficacy. Our approach is plug-and-play and works with most drugs and therapeutic classes.
101 College Street, New Haven, Connecticut 06510, United States
D2B3, Inc.
Copyright © 2024 D2B3 - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.